Oct. 6 at 5:55 PM
The B2i Digital team is pleased to introduce EUDA Health Holdings Limited (NASDAQ:
$EUDA) as a New and Notable company in our network. EUDA is a Singapore-based non-invasive healthcare provider focused on the longevity and wellness sectors across Asia.
Founded with a mission to transform regional healthcare from reactive to proactive care, EUDA addresses the wellness needs of aging populations across Singapore, Malaysia, and China. The company’s portfolio includes the Euda Helixé supplement line (management projects 500,000 bottles sold in the next 12 months), Bioenergy Capsules (targeting 1,000+ unit deployment), and advanced wellness solutions through strategic partnerships.
Recent business developments include Letters of Intent to acquire Chemokine Pte Ltd and GO POSB Organoids, distribution agreements with Guangdong Cell Biotech and Shenzhen Inno Immune (backed by Sequoia Capital), and plans for an iPSC laboratory in Shenzhen. These initiatives position EUDA within Asia’s longevity market, which third-party forecasts suggest could exceed
$2 trillion annually by 2030.
EUDA’s leadership team brings decades of industry experience: Alfred Lim, CEO (44-year veteran of cross-border trade, formerly Managing Director at Borealis Singapore); Vivian Tay, Interim CFO (former Audit Manager at Deloitte & Touche); Alex Lai, CEO of CK Health Plus (cross-industry expertise in digital marketing and operations); and Aaron Lim, Operational Director.
To learn more about EUDA Health Holdings Limited, visit https://www.asiastockwire.com/euda. For investor inquiries, visit https://1847846.ir365connect.com or contact
[email protected].
Discover more emerging growth Featured Companies, industry-leading Featured Experts, and upcoming Featured Conferences at https://b2idigital.com.
